NCT04984174Completed
Survival Rate and Treatment Cost in Patients With Pancreatic Cancer: An Analysis Using NHIS Database and K-PaC Registry Focusing on Liposomal Irinotecan
Survival Rate and Treatment Cost in Patients With Pancreatic Cancer With the Advent of New Chemotherapeutic Agents in Korea: An Analysis Using NHIS Database and K-PaC Registry Focusing on the Newest One, Liposomal Irinotecan
Source: ClinicalTrials.gov · Last updated 18 Jun 2025
Brief summary (registry, in English)
The past 15 years, using National Health Insurance Service (NHIS) database and K-PaC registry, and to analyze the cost and cost-effectiveness along with the change in survival rate after the emergence of the aforementioned regimens, which is very important for policy decisions such as reimbursement of second-line treatment.
- Status (registry)
- Completed
- Study type
- Observational
- Enrollment
- 14760 (actual)
- First submitted
- 16 Jul 2021
- Start date
- 4 Aug 2021
- Primary completion date
- 28 Dec 2024
- Lead sponsor
- National Cancer Center, Korea
- Diseases
- Pancreatic cancer, Childhood cancers
- NCT number
- NCT04984174
What you commit to
- Study type: Observational
- Participants enrolled: 14760
- From 4 Aug 2021 to the primary completion date, 28 Dec 2024
- 1 site in 1 country
- Visits and tests: ask the trial team, the registry does not list them
Built from the registry fields of ClinicalTrials.gov. It describes the study design.
Who cannot take part
Copied verbatim from ClinicalTrials.gov and grouped by topic. Only the trial team decides who can take part.
Other illness
- Patients who underwent surgery for pancreatic cancer
Who the study is looking for
- Pancreatic cancer patients with records of medical users and billing data from 2005 to 2020
Sex: All · Does not accept healthy volunteers
Sites (1)
Sites in registry order. Save your city in your profile to sort them by distance.
| Site | City | Country | Site status |
|---|---|---|---|
| NATIONAL CANCER CENTER 323, Ilsan-ro, Ilsandong-gu, Coordinator of this site? Confirm its status | Goyang-si | South Korea | Unknown status |
This page is information, not medical advice. Discuss any trial with your doctor.